Protease-activated receptors in cancer: A systematic review

被引：43
作者：
Han, Na [1 ,2 ]
Jin, Ketao [3 ,4 ]
He, Kuifeng [3 ]
Cao, Jiang [1 ,2 ,5 ]
Teng, Lisong [3 ]
机构：
[1] Zhejiang Univ, Sir Run Run Shaw Inst Clin Med, Hangzhou 310016, Zhejiang, Peoples R China
[2] Key Lab Biotherapy Zhejiang Prov, Hangzhou 310016, Zhejiang, Peoples R China
[3] Zhejiang Univ, Dept Surg Oncol, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China
[4] Wenzhou Med Coll, Zhuji Hosp, Dept Surg, Zhuji 311800, Zhejiang, Peoples R China
[5] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Clin Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China
来源：
ONCOLOGY LETTERS | 2011年 / 2卷 / 04期
基金：
中国国家自然科学基金;
关键词：
angiogenesis; cancer; protease-activated receptors; tumorigenesis; MOLECULAR-WEIGHT HEPARIN; ENDOTHELIAL GROWTH-FACTOR; THROMBIN-INDUCED ANGIOGENESIS; PEPDUCIN-BASED INTERVENTION; HUMAN PLATELET ACTIVATION; TUMOR-SUPPRESSOR PROTEIN; TISSUE FACTOR; IN-VITRO; CELL-PROLIFERATION; ANTIANGIOGENIC AGENTS;
D O I：
10.3892/ol.2011.291
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The traditional view of the role of proteases in tumor growth, progression and metastasis has significantly changed. Apart from their contribution to cancer progression, it is evident that a subclass of proteases, such as thrombin, serves as signal molecules controlling cell functions through the protease-activated receptors (PARs). Among the four types of PAR (PAR 1-4; cloned and named in order of their discovery), PAR1, PAR3 and PAR4 are activated by thrombin, unlike PAR2, which is activated by trypsin-like serine proteases. Thrombin has been proven to be a significant factor in both the behavior of cancer in its involvement in hemostasis and blood coagulation. Thrombin is a key supporter of various cellular effects relevant to tumor growth and metastasis, as well as a potent activator of angiogenesis, which is essential for the growth and development of all solid tumor types. This review presents an overview of the role of PAR-mediated thrombin in angiogenesis and cancer, focusing on the ability of PAR1- and PAR4-mediated thrombin to affect tumorigenesis and angiogenesis.
引用
收藏
页码：599 / 608
页数：10
相关论文
共 157 条
[1]   Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity [J].
Andersen, H ;
Greenberg, DL ;
Fujikawa, K ;
Xu, WF ;
Chung, DW ;
Davie, EW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) :11189-11193
[2]   Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor [J].
Andrade-Gordon, P ;
Mayanoff, BE ;
Derian, CK ;
Zhang, HC ;
Addo, MF ;
Darrow, AL ;
Eckardt, AJ ;
Hoekstra, WJ ;
McComsey, DF ;
Oksenberg, D ;
Reynolds, EE ;
Santulli, RJ ;
Scarborough, RM ;
Smith, CE ;
White, KB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) :12257-12262
[3]  
BENEZRA J, 1990, AM J PATHOL, V137, P755
[4]  
Bergmann S, 2006, ONCOL REP, V15, P889
[5]  
Bohm SK, 1996, BIOCHEM J, V314, P1009
[6]   Thrombin and platelet activation [J].
Brass, LF .
CHEST, 2003, 124 (03) :18S-25S
[7]  
Bromberg ME, 2001, THROMB HAEMOSTASIS, V86, P1210
[8]   REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS [J].
BROOKS, PC ;
CLARK, RAF ;
CHERESH, DA .
SCIENCE, 1994, 264 (5158) :569-571
[9]   Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3 [J].
Brooks, PC ;
Stromblad, S ;
Sanders, LC ;
vonSchalscha, TL ;
Aimes, RT ;
StetlerStevenson, WG ;
Quigley, JP ;
Cheresh, DA .
CELL, 1996, 85 (05) :683-693
[10]   The hemostatic system as a regulator of angiogenesis [J].
Browder, T ;
Folkman, J ;
Pirie-Shepherd, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (03) :1521-1524
12345678910